[City, State] – [Date] – Contemporary Care announces expansion of transcranial magnetic stimulation (TMS) services to address growing demand for this depression treatment. The practice now offers multiple TMS protocols including theta burst stimulation for individuals with treatment-resistant depression.

TMS Service Expansion

Treatment-resistant depression affects a significant portion of individuals diagnosed with major depressive disorder. These patients do not achieve adequate symptom relief despite trying multiple antidepressant medications at appropriate doses and durations.

TMS received FDA approval for treatment-resistant depression. The technology has evolved with refined protocols, improved equipment, and expanded applications.

TMS Mechanism

TMS uses magnetic fields to stimulate nerve cells in brain regions controlling mood. During treatment, a magnetic coil positioned against the scalp delivers brief pulses. These pulses pass through the skull and induce small electrical currents in targeted brain areas.

The dorsolateral prefrontal cortex, which shows decreased activity in depression, represents the primary target. Repeated stimulation increases neural activity in this region.

The procedure is non-invasive, requiring no anesthesia or sedation. Patients remain awake during treatment and can drive themselves to appointments. No cognitive side effects occur.

Available Protocols

Contemporary Care offers multiple TMS protocols. Standard TMS delivers pulses per session over treatment periods. Treatment courses involve daily sessions five days weekly for several weeks.

Theta burst stimulation represents a newer protocol delivering equivalent treatment in shorter timeframes. The accelerated approach uses intermittent bursts of high-frequency stimulation.

Bilateral protocols add right-sided stimulation using different parameters alongside left-sided treatment. The SAINT protocol compresses full treatment courses into several days through intensive daily sessions.

Clinical Experience

Contemporary Care has treated thousands of patients with TMS. Proper coil positioning, parameter optimization, and patient selection all influence results.

Technical expertise influences TMS outcomes. Experience with large patient volumes allows refinement of techniques.

Treatment Outcomes

Clinical trials demonstrate that many patients with treatment-resistant depression experience significant symptom reduction with TMS. A substantial portion achieve full remission of symptoms.

These outcomes are notable given the treatment-resistant populations being studied. Patients entering TMS trials have typically failed multiple antidepressant medications.

Effects typically persist after treatment completion. While some patients eventually require maintenance of TMS, many maintain improvement for extended periods.

Safety Profile

TMS has minimal side effects. Most patients experience only mild scalp discomfort or headaches that resolve quickly.

Seizure represents a potential risk, though occurrence is extremely rare. Screening excludes individuals with seizure risk factors.

No cognitive side effects occur with TMS. Memory, concentration, and other cognitive functions remain intact.

Patients can drive themselves to appointments and return to work immediately after sessions.

Patient Selection

Ideal TMS candidates have major depressive disorder with inadequate response to antidepressant medications. Most insurance plans require documentation of at least two failed medication trials.

Medical screening rules out contraindications including metallic implants in the head or face, history of seizures, or certain neurological conditions.

Motivation and ability to attend frequent appointments matter. The required schedule of daily sessions over several weeks demands commitment.

Contemporary Care's evaluation process identifies appropriate candidates and sets realistic expectations.

Equipment

Contemporary Care uses FDA-cleared TMS devices from NeuroStar and MagVenture. Multiple device availability allows equipment selection based on individual needs.

Regular equipment maintenance and calibration ensure consistent treatment delivery.

Insurance Coverage

Most commercial insurance plans and Medicare cover TMS for treatment-resistant depression. Coverage requires prior authorization with documentation of failed medication trials and current depression severity.

Contemporary Care's insurance coordinators handle authorization processes.

Expanded Applications

While FDA approval focuses on depression, research examines TMS applications for other conditions. Obsessive-compulsive disorder represents another FDA-approved indication.

Emerging evidence suggests TMS may benefit anxiety disorders, PTSD, and certain chronic pain conditions.

Integrated Treatment

TMS works within overall depression treatment plans. Continuing antidepressant medications and participating in psychotherapy support sustained improvement.

Contemporary Care's integrated model allows coordinated treatment planning. TMS specialists work alongside prescribers and therapists.

Service Locations

Contemporary Care operates TMS facilities in Connecticut, New York, and Florida. Multiple locations increase access for individuals across these regions.

About Contemporary Care

Contemporary Care is a psychiatric practice specializing in evidence-based treatment for depression, anxiety, ADHD, bipolar disorder, PTSD, and other mental health conditions.

In addition to TMS, Contemporary Care offers medication management, psychotherapy, and esketamine treatment. The practice operates locations in Connecticut, New York, and Florida, with telehealth services in multiple states.

Appointments are available by calling (800) 504-5185 or visiting contemporarycare.net.

Media Contact:
Contemporary Care
(800) 504-5185
contemporarycarehelp@contemporarycare.net